Literature DB >> 32926336

PTP1B and α-glucosidase inhibitors from Selaginella rolandi-principis and their glucose uptake stimulation.

Dinh-Tuan Nguyen1,2,3, Dao-Cuong To4,5, Thi-Tuyen Tran1, Manh-Hung Tran6, Phi-Hung Nguyen7,8.   

Abstract

As part of an ongoing search for new protein tyrosine phosphatase 1B inhibitors and glucose uptake stimulators from nature, a new coumarin, selaginolide A (1) and four known isoflavones (2‒5) were isolated from the ethanol extract of a Vietnamese medicinal plant Selaginella rolandi-principis. The chemical structures of the isolates were elucidated by extensive analysis of spectroscopic and physicochemical data. Compounds 3‒5 have been identified from Selaginella genus for the first time. The antidiabetic properties of the isolates (1‒5) were investigated using in vitro assay on 2-NBDG uptake in 3T3-L1 adipocytes and against PTP1B and α-glucosidase enzyme activities as well. Compounds 1 exhibited the most potency with inhibitory IC50 values of 7.40 ± 0.28 and 7.52 ± 0.37 µM against PTP1B and α-glucosidase, respectively. Compounds 3 and 5 possessed potential inhibitions on PTP1B enzyme with IC50 values of 23.02 ± 1.29 and 11.08 ± 0.92 µM and moderate inhibitions on α-glucosidase with IC50 values of 36.47 ± 1.87 and 55.73 ± 2.58 µM, respectively. Compounds 2 and 4 showed weak PTP1B inhibitory activity (IC50 > 30 µM) but displayed remarkable α-glucosidase inhibition with IC50 values of 3.39 ± 0.87 and 9.72 ± 0.62 µM, respectively. Furthermore, ursolic acid as a positive control (IC50 3.42 ± 0.26 µM) and compounds 1 and 5 acted as mixed-competitive inhibitors against PTP1B enzyme with Ki values of 6.46, 10.28, and 15.01 µM, respectively. In addition, compounds 1 and 5 also showed potent stimulatory effects on 2-NBDG uptake at a concentration of 10 µM. The obtained result might suggest the potential of new coumarin (1) as a new type of natural PTP1B and α-glucosidase inhibitor for further research and development of antidiabetic and obese agents.Graphic abstract.

Entities:  

Keywords:  2-NBDG; Coumarin; Diabetes; Isoflavone; PTP1B; Selaginella rolandi-principis; Selaginellaceae; α-glucosidase

Mesh:

Substances:

Year:  2020        PMID: 32926336     DOI: 10.1007/s11418-020-01448-z

Source DB:  PubMed          Journal:  J Nat Med        ISSN: 1340-3443            Impact factor:   2.343


  18 in total

1.  [Soviet neuropathology during World War II 1941-1945 ( on the 50th anniversary of the outbreak of World War II)].

Authors:  K F Kanareĭkin; L A Kukuev
Journal:  Zh Nevropatol Psikhiatr Im S S Korsakova       Date:  1991

2.  A phosphotyrosyl mimetic peptide reverses impairment of insulin-stimulated translocation of GLUT4 caused by overexpression of PTP1B in rat adipose cells.

Authors:  H Chen; L N Cong; Y Li; Z J Yao; L Wu; Z Y Zhang; T R Burke; M J Quon
Journal:  Biochemistry       Date:  1999-01-05       Impact factor: 3.162

3.  Reduction of heart failure by pharmacological inhibition or gene deletion of protein tyrosine phosphatase 1B.

Authors:  Elodie Gomez; Magali Vercauteren; Baptiste Kurtz; Antoine Ouvrard-Pascaud; Paul Mulder; Jean-Paul Henry; Marie Besnier; Aurélie Waget; Rob Hooft Van Huijsduijnen; Michel L Tremblay; Remy Burcelin; Christian Thuillez; Vincent Richard
Journal:  J Mol Cell Cardiol       Date:  2012-03-15       Impact factor: 5.000

4.  Tyrosine dephosphorylation and deactivation of insulin receptor substrate-1 by protein-tyrosine phosphatase 1B. Possible facilitation by the formation of a ternary complex with the Grb2 adaptor protein.

Authors:  B J Goldstein; A Bittner-Kowalczyk; M F White; M Harbeck
Journal:  J Biol Chem       Date:  2000-02-11       Impact factor: 5.157

Review 5.  Improving Adherence in Type 2 Diabetes.

Authors:  Khine Swe; S Sethu K Reddy
Journal:  Clin Geriatr Med       Date:  2020-04-17       Impact factor: 3.076

6.  Overexpression of protein-tyrosine phosphatase-1B in adipocytes inhibits insulin-stimulated phosphoinositide 3-kinase activity without altering glucose transport or Akt/Protein kinase B activation.

Authors:  C L Venable; E U Frevert; Y B Kim; B M Fischer; S Kamatkar; B G Neel; B B Kahn
Journal:  J Biol Chem       Date:  2000-06-16       Impact factor: 5.157

Review 7.  Protein tyrosine phosphatase 1B: a new target for the treatment of obesity and associated co-morbidities.

Authors:  O Ukkola; M Santaniemi
Journal:  J Intern Med       Date:  2002-06       Impact factor: 8.989

8.  Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene.

Authors:  M Elchebly; P Payette; E Michaliszyn; W Cromlish; S Collins; A L Loy; D Normandin; A Cheng; J Himms-Hagen; C C Chan; C Ramachandran; M J Gresser; M L Tremblay; B P Kennedy
Journal:  Science       Date:  1999-03-05       Impact factor: 47.728

Review 9.  Diabetes: What Challenges Lie Ahead for Vietnam?

Authors:  Nguyen Bich Ngoc; Zhou Lu Lin; Waqas Ahmed
Journal:  Ann Glob Health       Date:  2020-01-02       Impact factor: 2.462

10.  Protein tyrosine phosphatase 1B negatively regulates leptin signaling in a hypothalamic cell line.

Authors:  Wiweka Kaszubska; H Douglas Falls; Verlyn G Schaefer; Deanna Haasch; Leigh Frost; Paul Hessler; Paul E Kroeger; David W White; Michael R Jirousek; James M Trevillyan
Journal:  Mol Cell Endocrinol       Date:  2002-09-30       Impact factor: 4.102

View more
  3 in total

Review 1.  Approaches to Decrease Hyperglycemia by Targeting Impaired Hepatic Glucose Homeostasis Using Medicinal Plants.

Authors:  Gerardo Mata-Torres; Adolfo Andrade-Cetto; Fernanda Espinoza-Hernández
Journal:  Front Pharmacol       Date:  2021-12-23       Impact factor: 5.810

Review 2.  3-Phenylcoumarins as a Privileged Scaffold in Medicinal Chemistry: The Landmarks of the Past Decade.

Authors:  Maria J Matos; Eugenio Uriarte; Lourdes Santana
Journal:  Molecules       Date:  2021-11-08       Impact factor: 4.411

Review 3.  A Review of Coumarins and Coumarin-Related Compounds for Their Potential Antidiabetic Effect.

Authors:  Sara Ranđelović; Robbert Bipat
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2021-09-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.